Viral vectors serve as carriers for genetic material to be transferred into other living species. Viral vectors can be produced in two types of culture systems: suspension cell cultures and adherent-cell systems. Traditional lab procedures of adherent-cell systems such as multilayer flasks, hollow-fiber technologies, T-flasks, and roller bottles face scaling problems such as increased manual labour and bigger space requirements for large-scale viral vector synthesis.
Viral Vectors and Plasmid DNA Manufacturing has enabled major pharmaceutical companies to scale up their existing DNA technologies, making them more efficient and cheaper for medical and other applications. Moreover, the production of viral agents using modern technologies is capable of producing products with efficiencies comparable to those of commercial products at a fraction of the cost of commercial solutions. The final product must undergo stringent quality control procedures and be regularly monitored for quality assurance.
Read More@ https://bit.ly/3GqrzMf
